Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Suzie Carter, Laurence Amar et al.|Cancer Cell|2017Cited by 791
Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobin Park, Christine H. Chung, Jiannong Li et al.|Oral Oncology|2024Cited by 5
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Christine H. Chung, Graydon Moorhead et al.|Clinical Cancer Research|2025Cited by 3
Figure S12 from PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and ApoptosisSowjanya Thatikonda, Christine H. Chung, Ritu Chaudhary et al.|Unknown|2026Cited by 0
Figure S1 from PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and ApoptosisSowjanya Thatikonda, Christine H. Chung, Ritu Chaudhary et al.|Unknown|2026Cited by 0